Skip Navigation Links
 Home 
 Registration 
 Pre Registered 
  
 Personal page 
 Archive 
Scroll up
Scroll down
-
-
Scroll up
Scroll down
               
Skip Navigation Links
        صفحه اصلی
        ساختار همایش
        مکان برگزاری
        ثبت نام
        ثبت نام شدگان
         مقالات
        مقالات پذیرفته شده
        برنامه همایش
        تماس با ما
        صفحه شخصی
        جستجوی سخنران
        آرشیو سمينار سالهای گذشته
 
مقاله Abstract


Title: The Role of Interactive Binocular Treatment System in Amblyopia Therapy
Author(s): Zhale Rajavi, Hamideh Sabbaghi, Ebrahim Amini Sharifi, Narges Behradfar, Mehdi Yaseri
Presentation Type: Oral
Subject: Strabismus
Others:
Presenting Author:
Name: Hamideh Sabbaghi
Affiliation :(optional) Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
E mail: sabbaghi_h@yahoo.com
Phone: 22812609
Mobile: 09120285930
Purpose:

To determine the role of Interactive Binocular Treatment (I-BiTTM) as a complementary method of patching in amblyopia therapy.

Methods:

In this randomized clinical trial study, 50 unilateral amblyopic children (25 males/25 females) between 4 to 10 years with either BCVA≤20/30 in amblyopic eye or difference of VA≥2 lines between two eyes were included. They were randomly classified in case and control groups (25 in each). Patching was recommended in both, cases were also received I-BiTTM. Cases were asked to play I-BiTTM games through appropriate glasses with conjugate colored filters. Non-amblyopic eye looked at fixed image and non-amblyopic eye watched moving targets. Playing games were continued 30 minutes in each session for 5 days in each week within one month. Patching was continued for one month more in both groups. VA and stereoacuity were measured at baseline, one month at the end of I-BiTTM and one month after I-BiTTM.

Results:

The BCVA of amblyopic eyes were 0.34±0.15LogMAR at baseline and it was improved to 0.17±0.14 and 0.26±0.17 in cases and controls, respectively at the end of one month I-BiTTM. The difference was significant in each group (PCase<0.001, PControl=0.024) with more improvement in the case group (p<0.001). One month after cessation of I-BiTTM, the BCVA difference between two groups was not statistically significant. There was no case with recurrence of amblyopia.

Conclusion:

Based on our results, I-BiTTM has an effective role in amblyopia therapy while accompanied with patching. We recommend the comparing of I-BiTTM alone with patching in further studies.

Attachment:





Last News

  -